Adenovirus serotype 26 vectors, nucleic acid and viruses produced thereby

Details for Australian Patent Application No. 2006212885 (hide)

Owner Merck & Co., Inc.

Inventors Kaslow, David C.; Emini, Emilio A.; Shiver, John W.; Bett, Andrew J.; Casimiro, Danilo R.; Chastain, Michael

Agent Spruson & Ferguson

Pub. Number AU-A-2006212885

PCT Pub. Number WO2006/086284

Priority 60/652,041 11.02.05 US

Filing date 7 February 2006

Wipo publication date 17 August 2006

International Classifications

C12Q 1/70 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving virus or bacteriophage

Event Publications

26 July 2007 PCT application entered the National Phase

  PCT publication WO2006/086284 Priority application(s): WO2006/086284

1 September 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006212889-Methods for reducing the symptoms of autoimmunity and inflammation using binding proteins against antigens exposed on dead or dying cells

2006212881-Convertible traction shoes